A calculator to predict benefit from adjuvant transarterial chemoembolization for hepatocellular carcinoma
Hepatocellular carcinoma (HCC) is the most commonly diagnosed cancer of the liver and the fourth leading cause of cancer-related mortality worldwide, with China accounting for over half of the global annual cases and deaths. ...
Aug 22, 2023
0
12